STOCK TITAN

[Form 4] Pluri Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Pluri Inc. director Rami Avraham Levi reported a stock-based compensation grant on Form 4. On December 4, 2025, he acquired 653 shares of Pluri common stock as restricted stock units at a stated price of $0 per share under the company’s 2019 Equity Compensation Plan. Following this grant, he beneficially owned 18,967 shares of common stock in total. The RSUs were approved by the Board of Directors and are scheduled to vest in equal monthly installments over three months after the grant date, providing short-term, time-based equity incentives linked to continued service.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Levi Rami Avraham

(Last) (First) (Middle)
C/O PLURI INC.
MATAM ADVANCED TECH PARK BUILDING 5

(Street)
HAIFA L3 3508409

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Pluri Inc. [ PLUR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/04/2025(1) A 653(1) A $0 18,967 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The restricted stock units ("RSUs") were approved for grant by the Board of Directors on December 4, 2025, under the Company's 2019 Equity Compensation Plan. The RSUs vest equally on a monthly basis over three months following the date of grant.
/s/ Rami Avraham Levi 12/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Pluri Inc. (PLUR) report in this Form 4?

Pluri Inc. reported that director Rami Avraham Levi acquired 653 restricted stock units of common stock on December 4, 2025 as stock-based compensation.

At what price were the Pluri Inc. (PLUR) RSUs granted to the director?

The 653 RSUs of Pluri Inc. common stock were reported with a price of $0 per share, reflecting an equity award rather than an open-market purchase.

How do the new RSUs for Pluri Inc. (PLUR) director vest?

The restricted stock units granted on December 4, 2025 vest equally on a monthly basis over three months following the grant date.

Under which plan were the Pluri Inc. (PLUR) RSUs granted to the director?

The 653 RSUs were approved by the Board of Directors under Pluri Inc.’s 2019 Equity Compensation Plan.

How many Pluri Inc. (PLUR) shares does the reporting person own after this transaction?

After receiving the 653 RSUs, director Rami Avraham Levi beneficially owned 18,967 shares of Pluri Inc. common stock in total.

What is the reporting person’s relationship to Pluri Inc. (PLUR)?

The reporting person, Rami Avraham Levi, is identified in the filing as a director of Pluri Inc.

Pluri Inc

NASDAQ:PLUR

PLUR Rankings

PLUR Latest News

PLUR Latest SEC Filings

PLUR Stock Data

31.46M
7.94M
43.41%
19.65%
0.31%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Israel
HAIFA